Details for 2017810848
Up to date per 04.04.2026
Actions
Details for 2017810848
Granted/Registered
European Patent
10.04.2019 A
04.03.2026 B1
06.06.2016
US
201662346209 P
27.02.2017
US
201762464209 P
C12N 9/16 20060101AFI20200115BHEP
Owner
Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US
Representative
No representatives present
Inventor
RAJENDRAN, Saravanamoorthy100 College Street New Haven, CT 06510US
ALFORD, Rachael100 College Street New Haven, CT 06510US
GALLAGHER, Sean100 College Street New Haven, CT 06510US
KANTARDJIEFF, Anne100 College Street New Haven, CT 06510US
DAVIS, Jared100 College Street New Haven, CT 06510US
Information about Fees